Detalles de la búsqueda
1.
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms.
J Mol Diagn
; 26(3): 168-178, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103591
2.
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison.
J Mol Diagn
; 25(6): 352-366, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963483
3.
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry.
J Mol Diagn
; 23(2): 181-199, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33217553
4.
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms.
J Mol Diagn
; 21(2): 330-342, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30590126
Resultados
1 -
4
de 4
1
Próxima >
>>